11/14/2024
2:05 PM | Cormorant Asset Management, LP (Filed by)
TScan Therapeutics (Subject)
| Form SC 13G/A | |
11/08/2024
1:17 PM | BlackRock, Inc. (Filed by)
TScan Therapeutics (Subject)
| Form SC 13G | |
11/01/2024
6:00 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/21/2024
3:11 PM | BlackRock, Inc. (Filed by)
TScan Therapeutics (Subject)
| Form SC 13G | |
09/24/2024
4:26 PM | Klencke Barbara (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2024
5:46 PM | TScan Therapeutics (Issuer)
ZDRAVESKI ZORAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2024
5:57 PM | Klencke Barbara (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
08/23/2024
4:50 PM | TScan Therapeutics (Subject)
ZDRAVESKI ZORAN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/12/2024
6:30 AM | TScan Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024
6:15 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2024
3:20 PM | Nicholson Garry A (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:20 PM | Gruia Gabriela (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:20 PM | Klencke Barbara (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:20 PM | Dorton Katina (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:20 PM | TScan Therapeutics (Issuer)
Woods Keith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
6:15 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
6:15 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
6:30 AM | TScan Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/03/2024
3:05 PM | Louis Chrystal (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2024
3:17 PM | 667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2024
3:25 PM | BAKER BROS. ADVISORS LP (Filed by)
TScan Therapeutics (Subject)
| Form SC 13D/A | |
04/23/2024
3:15 PM | Lynx1 Capital Management LP (Reporting)
Nichols Weston (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
8:58 PM | TScan Therapeutics (Filer)
| Form 424B5 | |
04/17/2024
5:25 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/17/2024
5:20 AM | TScan Therapeutics (Subject)
| Form FWP | |
04/16/2024
4:21 PM | TScan Therapeutics (Filer)
| Form 424B5 | |
04/16/2024
3:16 PM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/14/2024
11:15 PM | TScan Therapeutics (Filer)
| Form EFFECT | |
04/10/2024
6:30 AM | TScan Therapeutics (Filer)
| Form 10-K/A | |
04/08/2024
7:17 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
6:30 AM | TScan Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/06/2024
6:15 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
3:45 PM | K2 HealthVentures Equity Trust LLC (Filed by)
TScan Therapeutics (Subject)
| Form SC 13G/A | |
02/08/2024
5:02 AM | Pitango HealthTech Fund I, L.P. (Filed by)
TScan Therapeutics (Subject)
| Form SC 13G/A | |
02/07/2024
6:45 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
TScan Therapeutics (Subject)
| Form SC 13G/A | |
02/02/2024
3:21 PM | Amello Jason (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
6:15 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/21/2023
4:00 PM | BARBERICH TIMOTHY J (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
5:01 PM | Klencke Barbara (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
7:00 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/08/2023
7:15 AM | TScan Therapeutics (Issuer)
TScan Therapeutics (Issuer)
Woods Keith (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
The Crypto That’s Making Wall Street Sweat (Ad) The Crypto Wall Street Is Desperate to Hide
It's happening now, right under everyone's radar. Big tech giants are quietly integrating it. Venture capitalists are scrambling to invest. Click here to discover our #1 crypto for the market right now – poised for massive growth |
12/08/2023
7:20 AM | TScan Therapeutics (Issuer)
TScan Therapeutics (Issuer)
Woods Keith (Reporting)
Woods Keith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
6:15 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free TCRX Stock Alerts